Virtual Medicinal Product (VMP) - Lorazepam 4mg/1ml solution for injection ampoules

Navigation

Name Details

Name Start Date End Date
Name Current Name Lorazepam 4mg/1ml solution for injection ampoules Start Date 04-06-2004 End Date
Previous Name Previous Name Lorazepam 4mg/ml injection 1ml ampoules Start Date 19-02-2003 End Date 03-06-2004

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
ml
Unit Dose UOM
ampoule

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
Schedule 4 (CD Benz)
Route
Intravenous, Intramuscular
Form
Solution for injection
Ontology Form/Route
solutioninjection.intramuscular, solutioninjection.intravenous
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
N05BA06
BNF Start Date End Date
Current BNF 04010200 Start Date 04-04-2022 End Date
Previous BNF 04080200 Start Date 01-02-2005 End Date 03-04-2022
Previous BNF 04010200 Start Date 01-02-2005 End Date 03-04-2022
Previous BNF 15010401 Start Date 01-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
36040511000001101 29-10-2018
321302003 19-02-2003 28-10-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Lorazepam Based on Ingredient Substance 4 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
10 ampoule 15000 Part VIIIA Category C